Daniel Grosslight
Stock Analyst at Citi
(3.51)
# 2,310
Out of 4,692 analysts
377
Total ratings
49.8%
Success rate
3.9%
Average return
Main Sectors:
Stocks Rated by Daniel Grosslight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAH Cardinal Health | Maintained: Buy | $265 → $280 | $234.62 | +19.34% | 21 | Aug 12, 2026 | |
| HIMS Hims & Hers Health | Maintained: Hold | $35 → $33 | $29.58 | +11.56% | 51 | Aug 12, 2026 | |
| ACH Accendra Health | Downgraded: Hold | $4.5 → $1.5 | $1.21 | +23.97% | 26 | Aug 11, 2026 | |
| ZTS Zoetis | Maintained: Buy | $112 → $96 | $77.10 | +24.51% | 3 | Aug 11, 2026 | |
| EVH Evolent Health | Upgraded: Buy | $6.75 → $6 | $4.50 | +33.33% | 13 | Aug 11, 2026 | |
| GDRX GoodRx Holdings | Maintained: Buy | $4 → $5 | $3.49 | +43.27% | 31 | Aug 11, 2026 | |
| AGL agilon health | Upgraded: Hold | $105 → $115 | $87.89 | +30.85% | 12 | Aug 11, 2026 | |
| MCK McKesson | Reiterated: Buy | $1,000 | $885.32 | +12.95% | 17 | Aug 10, 2026 | |
| HCAT Health Catalyst | Reiterated: Hold | $2.5 → $2 | $1.64 | +21.95% | 20 | Aug 10, 2026 | |
| NVST Envista Holdings | Reiterated: Hold | $29 → $32 | $27.14 | +17.91% | 2 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $45 | $39.83 | +12.98% | 24 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $20.49 | +70.82% | 7 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $355 → $370 | $323.60 | +14.34% | 15 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $34 | $23.92 | +42.14% | 3 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $330 | $386.12 | -14.53% | 1 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 → $112 | $89.80 | +24.72% | 2 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $650 → $670 | $556.69 | +20.35% | 2 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $35.03 | +28.46% | 1 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $240 | $159.79 | +50.20% | 3 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 → $7.5 | $6.34 | +18.30% | 40 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $26.18 | +6.95% | 10 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $12.15 | +39.92% | 1 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $12 | $12.21 | -1.72% | 24 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $62 → $44 | $37.74 | +16.59% | 2 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $10 → $11 | $11.17 | -6.00% | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $21.96 | n/a | 1 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.25 → $1.75 | $0.56 | n/a | 10 | Sep 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $19 → $8 | $12.62 | n/a | 9 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $9 | $1.13 | n/a | 14 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $15 → $11 | $0.0001 | n/a | 6 | Mar 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.15 → $0.45 | $0.000001 | n/a | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $5.59 | n/a | 1 | Dec 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $25.59 | n/a | 1 | Nov 19, 2019 |
Cardinal Health
Aug 12, 2026
Maintained: Buy
Price Target: $265 → $280
Current: $234.62
Upside: +19.34%
Hims & Hers Health
Aug 12, 2026
Maintained: Hold
Price Target: $35 → $33
Current: $29.58
Upside: +11.56%
Accendra Health
Aug 11, 2026
Downgraded: Hold
Price Target: $4.5 → $1.5
Current: $1.21
Upside: +23.97%
Zoetis
Aug 11, 2026
Maintained: Buy
Price Target: $112 → $96
Current: $77.10
Upside: +24.51%
Evolent Health
Aug 11, 2026
Upgraded: Buy
Price Target: $6.75 → $6
Current: $4.50
Upside: +33.33%
GoodRx Holdings
Aug 11, 2026
Maintained: Buy
Price Target: $4 → $5
Current: $3.49
Upside: +43.27%
agilon health
Aug 11, 2026
Upgraded: Hold
Price Target: $105 → $115
Current: $87.89
Upside: +30.85%
McKesson
Aug 10, 2026
Reiterated: Buy
Price Target: $1,000
Current: $885.32
Upside: +12.95%
Health Catalyst
Aug 10, 2026
Reiterated: Hold
Price Target: $2.5 → $2
Current: $1.64
Upside: +21.95%
Envista Holdings
Aug 10, 2026
Reiterated: Hold
Price Target: $29 → $32
Current: $27.14
Upside: +17.91%
Aug 10, 2026
Maintained: Buy
Price Target: $40 → $45
Current: $39.83
Upside: +12.98%
Aug 10, 2026
Reiterated: Buy
Price Target: $35
Current: $20.49
Upside: +70.82%
Aug 6, 2026
Maintained: Buy
Price Target: $355 → $370
Current: $323.60
Upside: +14.34%
Aug 6, 2026
Maintained: Buy
Price Target: $31 → $34
Current: $23.92
Upside: +42.14%
Aug 5, 2026
Maintained: Hold
Price Target: $330
Current: $386.12
Upside: -14.53%
Aug 5, 2026
Maintained: Buy
Price Target: $100 → $112
Current: $89.80
Upside: +24.72%
Aug 5, 2026
Maintained: Hold
Price Target: $650 → $670
Current: $556.69
Upside: +20.35%
Aug 5, 2026
Maintained: Buy
Price Target: $45
Current: $35.03
Upside: +28.46%
Aug 3, 2026
Reiterated: Buy
Price Target: $240
Current: $159.79
Upside: +50.20%
Aug 3, 2026
Maintained: Hold
Price Target: $11 → $7.5
Current: $6.34
Upside: +18.30%
Aug 3, 2026
Maintained: Buy
Price Target: $28
Current: $26.18
Upside: +6.95%
Jun 8, 2026
Initiated Coverage: Buy
Price Target: $17
Current: $12.15
Upside: +39.92%
May 28, 2026
Reiterated: Hold
Price Target: $10 → $12
Current: $12.21
Upside: -1.72%
May 14, 2026
Rated: Hold
Price Target: $62 → $44
Current: $37.74
Upside: +16.59%
May 6, 2026
Maintained: Sell
Price Target: $10 → $11
Current: $11.17
Upside: -6.00%
May 29, 2024
Maintained: Buy
Price Target: n/a
Current: $21.96
Upside: n/a
Sep 14, 2023
Maintained: Hold
Price Target: $1.25 → $1.75
Current: $0.56
Upside: n/a
Aug 4, 2023
Downgraded: Sell
Price Target: $19 → $8
Current: $12.62
Upside: n/a
May 18, 2023
Maintained: Hold
Price Target: $7 → $9
Current: $1.13
Upside: n/a
Mar 9, 2023
Maintained: Hold
Price Target: $15 → $11
Current: $0.0001
Upside: n/a
Nov 15, 2022
Maintained: Hold
Price Target: $1.15 → $0.45
Current: $0.000001
Upside: n/a
Dec 11, 2019
Initiated Coverage: Buy
Price Target: $13
Current: $5.59
Upside: n/a
Nov 19, 2019
Initiated Coverage: Buy
Price Target: $28
Current: $25.59
Upside: n/a